公共医疗上诉和政府在线响应:基于中国数字治理平台的大数据分析
Hebin Li1, Zhihan Liu1, Ziyan Zhang1
1School of Public Administration, Central South University, 20 Shaoshan South Road, Tianxin District, Changsha, 410004, China, 86 0731-88876916.
Journal of medical Internet research
|August 6, 2025
概括
在中国,政府对在线健康呼吁的响应是由宏观环境因素驱动的,而不是信息内容. 更高的互联网透率,教育和GDP增加了反应,而更强大的工会减少了它们.
科学领域:
- 数字健康数字健康
- 公共卫生政策 公共卫生政策
- 电子治理 (E-Governance) 是一个电子治理系统.
背景情况:
- 在线公众呼吁是公民表达医疗保健需求的关键道.
- 基于互联网的治理放大了这些数字互动的重要性.
研究的目的:
- 分析政府对中国公共医疗上诉的行动的主题结构,情绪基调和响应逻辑.
- 确定影响政府应对在线健康问题的因素.
主要方法:
- 从人民日报在线 (2022年1月至2023年11月) 分析了8864个有效的医疗上诉.
- 通过术语频率-反向文档频率 (TF-IDF) 和集群分析进行主题识别.
- 使用监督机器学习和基于词典的方法进行情感分类.
- 后勤回归和Probit模型用于评估文本,交易和宏观环境对响应能力的影响.
主要成果:
- 关于疫情控制,生育,医疗机构和保险的上诉中主要是负面的情绪.
- 文本特征,问题的复杂性和利益归因与政府反应没有显著的相关性.
- 诸如互联网普及率,教育和经济发展等宏观环境因素对响应能力产生了积极影响.
- 更强大的工会与政府响应率的下降有关.
结论:
- 中国的在线医疗上诉的特点是紧迫性,政策链接,服务效率/成本问题,保险挑战和负面情绪.
- 政府的响应能力主要受到宏观层面的因素的影响,而不是特定的吸引力内容.
- 结果为优化数字健康平台和推进健康信息传播和数字治理提供了洞察力.
更多相关视频
相关概念视频
01:18Steps in Outbreak Investigation
204
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
204
01:29Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
246
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
246